Expert review of clinical immunology · 2026
The relationship between MMP-2 and TIMP-2 gene polymorphisms and skin barrier function, inflammatory cytokine levels in acne patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang Suling, Fang Lijia, Zhang Meina, Sun Shuxian, Zhi Huixian, Zhu Yuguang, Zhang Hong
Аннотация
OBJECTIVE: This study aimed to investigate the association between MMP-2 rs243865 and TIMP-2 rs8179090 gene polymorphisms and skin barrier function, as well as inflammatory cytokine levels, in acne patients, to explore potential genetic mechanisms underlying acne pathogenesis.
METHODS: A total of 200 acne patients and 100 healthy controls were enrolled. Genotyping was performed using PCR-RFLP. Skin barrier function was assessed via transepidermal water loss (TEWL) and hydration measurements. Serum levels of IL-1β and TNF-α were quantified by ELISA. Statistical analyses included Pearson correlation and logistic regression.
RESULTS: The MMP-2-CC and TIMP-2-CC genotypes were significantly more prevalent in acne patients (p < 0.05). These genotypes correlated with higher TEWL (p < 0.05), reduced skin hydration (p < 0.05), and elevated IL-1β and TNF-α levels (p < 0.05) compared to CT/TT genotypes. Logistic regression confirmed associations between CC genotypes and increased acne severity (OR = 1.86-2.24).
CONCLUSION: The MMP-2 and TIMP-2 CC genotypes are linked to impaired skin barrier function and heightened inflammation in acne, suggesting their role in genetic susceptibility and disease progression. These findings may inform future targeted therapies.
CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov identifier is NCT07069075.
METHODS: A total of 200 acne patients and 100 healthy controls were enrolled. Genotyping was performed using PCR-RFLP. Skin barrier function was assessed via transepidermal water loss (TEWL) and hydration measurements. Serum levels of IL-1β and TNF-α were quantified by ELISA. Statistical analyses included Pearson correlation and logistic regression.
RESULTS: The MMP-2-CC and TIMP-2-CC genotypes were significantly more prevalent in acne patients (p < 0.05). These genotypes correlated with higher TEWL (p < 0.05), reduced skin hydration (p < 0.05), and elevated IL-1β and TNF-α levels (p < 0.05) compared to CT/TT genotypes. Logistic regression confirmed associations between CC genotypes and increased acne severity (OR = 1.86-2.24).
CONCLUSION: The MMP-2 and TIMP-2 CC genotypes are linked to impaired skin barrier function and heightened inflammation in acne, suggesting their role in genetic susceptibility and disease progression. These findings may inform future targeted therapies.
CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov identifier is NCT07069075.